Results for
""Lopinavir""[mesh_terms]

Thermodynamic Perspectives on the Impact of a Second Drug on Amorphous Drug Solubility.

Shun Kaneko, Kenjirou Higashi, Kunikazu Moribe, Keisuke Ueda, Masataka Ito, Rei Hakata, Shuji Noguchi

Molecular pharmaceutics 2025;22(7):4091-4100

Can Zn Be a Critical Element in COVID-19 Treatment?

Mohammad Tariqur Rahman, Syed Zahir Idid

Biological trace element research 2021;199(2):550-558

Efficacy and Safety of Lopinavir/Ritonavir or Arbidol in Adult Patients with Mild/Moderate COVID-19: An Exploratory Randomized Controlled Trial.

Yueping Li, Zhiwei Xie, Weiyin Lin, Weiping Cai, Chunyan Wen, Yujuan Guan, Xiaoneng Mo, Jian Wang, Yaping Wang, Ping Peng, Xudan Chen, Wenxin Hong, Guangming Xiao, Jinxin Liu, Lieguang Zhang, Fengyu Hu, Feng Li, Fuchun Zhang, Xilong Deng, Linghua Li

Med (New York, N.Y.) 2022;1(1):105-113.e4

Vitamin D status and associated factors among HIV-infected children and adolescents on antiretroviral therapy in Kampala, Uganda.

Thereza Were Piloya, Sabrina Bakeera-Kitaka, Grace Paul Kisitu, Richard Idro, Sarah E Cusick

PloS one 2021;16(6):e0253689

The safety and tolerability of switching from a non-failing antiretroviral regimen to lopinavir.

Y Gilleece, S Mandalia, D Parmar, M Nelson

The Journal of infection 2003;46(3):204-5

Bone mineral density over 96 weeks in adults failing first-line therapy randomized to raltegravir/lopinavir/ritonavir compared with standard second-line therapy.

Hila Haskelberg, Patrick W G Mallon, Jennifer Hoy, Janaki Amin, Cecilia Moore, Praphan Phanuphak, Samuel Ferret, Waldo H Belloso, Mark A Boyd, David A Cooper, Sean Emery

Journal of acquired immune deficiency syndromes (1999) 2015;67(2):161-8

Safety and efficacy of lopinavir/ritonavir combination in COVID-19: A systematic review, meta-analysis, and meta-regression analysis.

Anusuya Bhattacharyya, Subodh Kumar, Phulen Sarma, Hardeep Kaur, Manisha Prajapat, Nishant Shekhar, Seema Bansal, Pramod Avti, Mythili Hazarika, Saurabh Sharma, Dhruv Mahendru, Ajay Prakash, Bikash Medhi

Indian journal of pharmacology 2020;52(4):313-323

Meta-analysis of arbidol versus lopinavir/ritonavir in the treatment of coronavirus disease 2019.

Miao Yu, Deng-Chao Wang, Sheng Li, Yue-Hua Lei, Jian Wei, Li-Yan Huang

Journal of medical virology 2022;94(4):1513-1522

The SWITCHMRK studies: substitution of lopinavir/ritonavir with raltegravir in HIV-positive individuals.

Jennifer Cocohoba

Expert review of anti-infective therapy 2010;7(10):1159-63

Raltegravir non-inferior to nucleoside based regimens in second-line therapy with lopinavir/ritonavir over 96 weeks: a randomised open label study for the treatment of HIV-1 infection.

Janaki Amin, Mark A Boyd, Nagalingeswaran Kumarasamy, Cecilia L Moore, Marcello H Losso, Chidi A Nwizu, Lerato Mohapi, Stephen J Kerr, Annette H Sohn, Hedy Teppler, Boris Renjifo, Jean-Michel Molina, Sean Emery, David A Cooper

PloS one 2016;10(2):e0118228

Pharmacokinetics, the Immunological Impact, and the Effect on HIV Infectivity of Maraviroc, Raltegravir, and Lopinavir in Men Who Have Sex with Men Using Postexposure Prophylaxis.

Lorna Leal, Alberto C Guardo, Luis M Bedoya, Cristina Rodríguez de Miguel, Núria Climent, Cristina Rovira, Manuela Beltrán, Josep Llach, Jose Alcamí, Angela D M Kashuba, Jose M Gatell, Montserrat Plana, Felipe García

AIDS research and human retroviruses 2023;39(5):211-221

Lipid profiles in young HIV-infected children initiating and changing antiretroviral therapy.

Renate Strehlau, Ashraf Coovadia, Elaine J Abrams, Leigh Martens, Stephen Arpadi, Tammy Meyers, Louise Kuhn

Journal of acquired immune deficiency syndromes (1999) 2012;60(4):369-76

Sex differences in responses to antiretroviral treatment in South African HIV-infected children on ritonavir-boosted lopinavir- and nevirapine-based treatment.

Stephanie Shiau, Louise Kuhn, Renate Strehlau, Leigh Martens, Helen McIlleron, Sandra Meredith, Lubbe Wiesner, Ashraf Coovadia, Elaine J Abrams, Stephen M Arpadi

BMC pediatrics 2014;14():39

Seven-year efficacy of a lopinavir/ritonavir-based regimen in antiretroviral-naïve HIV-1-infected patients.

Robert L Murphy, Barbara A da Silva, Charles B Hicks, Joseph J Eron, Roy M Gulick, Melanie A Thompson, Florence McMillan, Martin S King, George J Hanna, Scott C Brun

HIV clinical trials 2008;9(1):1-10